Hepatocellular carcinoma (HCC) is an aggressive disease with a poor clinical outcome. The
cancer stem cell (CSC) model states that tumour growth is powered by a subset of tumour …

MicroRNAs (miRNAs) are small, non-coding RNAs that post-transcriptionally regulate gene
expression by binding to specific mRNA targets and promoting their degradation and/or …

Recent biomedical discoveries have revolutionized the concept and understanding of
carcinogenesis, a complex and multistep phenomenon which involves accretion of genetic …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths
worldwide. HCC initiation, progression, and therapy failure are all influenced by various …

Hepatocellular carcinoma (HCC) is well-known to be a highly prevalent malignant tumor, but
the treatment of this pathological state has been still challenging. Solamargine (SM), a …

Cancer stem cells (CSCs) are the key factor in determining cancer recurrence, metastasis,
chemoresistance and patient prognosis in hepatocellular carcinoma (HCC). The role of miR …

MicroRNAs (miRNAs) are a type of small non-coding RNAs that play an essential role in
numerous biological processes by regulating the post-transcriptional expression of target …

Background and Aims Transarterial chemoembolization (TACE) is a standard locoregional
therapy for patients with hepatocellular carcinoma (HCC) patients with a variable overall …

MicroRNAs (miRNAs) are non-coding small RNAs that can function as gene regulators and
are involved in tumorigenesis. We review the commonly dysregulated miRNAs in liver tumor …

Early hepatocellular carcinoma (HCC) diagnosis is challenging. Moreover, for patients with
alpha-fetoprotein (AFP)-negative HCC, this challenge is augmented. MicroRNAs (miRs) …